Political uncertainty from the historic impeachment trial of President Donald Trump and what’s sure to be a contentious presidential election in November won’t throw cold water on U.S. healthcare investment, Fitch Ratings said in a new report. Despite the potential for regulatory change late in the year, the outlook for healthcare products and services remains strong and the frenetic pace of mergers and acquisitions is unlikely to slow, though the scale of megadeals seen in recent years may ebb, according to the agency. Outside threats to pricing power will continue to spur consolidation both vertically and horizontally, Fitch predicts, though it’s likely M&A will be weighted toward the first half of the year as the election throws a wrench in the timing for raising capital.
Read the full article: Impeachment Trial, Election Won’t Dampen Health Investment, Fitch Says //
Source: https://www.healthcaredive.com/news/impeachment-trial-election-wont-dampen-health-investment-fitch-says/571038